Deep Genomics Company
Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.
Investors
Technology:
Artificial Intelligence, Biotechnology, Genetics, Therapeutics
Industry:
AI
Headquarters:
Toronto, Ontario, Canada
Founded Date:
01.01.2014
Employees Number:
101-250
Funding Status:
Late Stage Venture
Investors Number:
15
Total Funding:
2,37E+08
Estimated Revenue:
$1M to $10M
Last Funding Date:
28.07.2021
Last Funding Type:
Series C
Register and Claim Ownership